LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹43 Cr | ₹41 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹41 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | 0.35 | |
| Mar2024 | ₹32 Cr | -7.30 | |
| Mar2023 | ₹34 Cr | -20.24 | |
| Mar2022 | ₹43 Cr | 3.93 | |
| Mar2021 | ₹41 Cr | - | |
Compare Contingent Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹206.5 Cr | -3.8% | -15.5% | -41.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -3.8% |
-15.5% |
-41.6% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses